Searle & Co’s Cogentix Medical, Inc. CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-10,000
Closed -$39K 137
2018
Q1
$39K Hold
10,000
0.03% 131
2017
Q4
$32K Hold
10,000
0.02% 129
2017
Q3
$26K Hold
10,000
0.02% 127
2017
Q2
$17K Hold
10,000
0.01% 127
2017
Q1
$18K Buy
+10,000
New +$19.8K 0.01% 131
2016
Q4
Sell
-10,000
Closed -$18K 117
2016
Q3
$18K Buy
+10,000
New +$12.9K 0.02% 114
2016
Q2
Sell
-10,000
Closed -$11K 103
2016
Q1
$11K Hold
10,000
0.01% 111
2015
Q4
$12K Hold
10,000
0.01% 111
2015
Q3
$12K Hold
10,000
0.01% 104
2015
Q2
$16K Buy
+10,000
New +$16.4K 0.01% 249

Searle & Co's CGNT Position: Q2 2018 in Review

Searle & Co sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 10,000 shares — an estimated $39K sold.

Searle & Co first reported a position in CGNT in Q2 2015 and held it in 10 quarters. The position peaked at $39K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

  • Searle & Co reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
  • Searle & Co sold 10,000 Cogentix Medical, Inc. shares in Q2 2018, an estimated $39K.
  • Searle & Co first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 10 quarters.
  • Searle & Co's Cogentix Medical, Inc. position peaked at $39K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Searle & Co's 13F filing for Q2 2018, filed 19 Jul 2018.